Market Insights Health Medical Technology Medical Devices

Diabetes Care Devices - Netherlands

Netherlands

Revenue in the Diabetes Care Devices market market in the Netherlands is anticipated to attain €268.60m in 2024.
This revenue is projected to exhibit an annual growth rate (CAGR 2024-2029) of 12.40%, leading to a market volume of €481.80m by 2029.
In a global context, the highest revenue is expected to be generated the United States, with figures reaching €10,860.00m in 2024.
The Netherlands is witnessing a significant rise in demand for innovative diabetes care devices, driven by increasing health awareness and advanced healthcare infrastructure.

Key regions: Netherlands, Japan, France, Italy, China

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Diabetes Care Devices Market in the Netherlands is experiencing considerable growth, propelled by advancements in technology, increasing prevalence of diabetes, and heightened awareness about effective management solutions among patients and healthcare providers.

Customer preferences: Consumers in the Netherlands are increasingly prioritizing personalized diabetes management solutions, reflecting a cultural shift towards self-empowerment in health care. This trend is evident in the rising demand for smart insulin pens and continuous glucose monitors that offer real-time data and insights. Additionally, a growing preference for telehealth services is reshaping how patients interact with healthcare providers, allowing for more flexible and accessible diabetes management. As awareness of healthy lifestyles expands, patients are also seeking integrated solutions that combine dietary guidance with device functionality.

Trends in the market: In the Netherlands, the Diabetes Care Devices Market is experiencing a significant shift towards personalized management solutions, driven by a growing consumer demand for smart insulin pens and continuous glucose monitors that provide real-time data. This trend reflects an increasing emphasis on self-empowerment in healthcare, as patients seek tools that enhance their ability to manage diabetes effectively. Additionally, the rise of telehealth services is transforming patient-provider interactions, offering more flexible management options. As health awareness grows, there is a notable interest in integrated solutions that combine dietary guidance with device functionality, signaling opportunities for industry stakeholders to innovate and adapt to evolving consumer needs.

Local special circumstances: In the Netherlands, the Diabetes Care Devices Market is shaped by a robust healthcare infrastructure and a high level of health literacy among the population. The country's commitment to universal healthcare ensures that innovative diabetes management tools are accessible, fostering a culture of preventive care. Furthermore, Dutch regulations support the adoption of advanced medical technologies, facilitating quicker market entry for new devices. This environment encourages collaboration between tech startups and established healthcare providers, driving the development of integrated solutions tailored to individual patient needs.

Underlying macroeconomic factors: The Diabetes Care Devices Market in the Netherlands is significantly influenced by macroeconomic factors including national economic stability, healthcare funding, and demographic trends. The robust Dutch economy, characterized by low unemployment and high GDP per capita, supports increased healthcare spending, enabling innovation in diabetes management technologies. Fiscal policies promoting research and development further stimulate the market, while an aging population and rising diabetes prevalence create heightened demand for effective care solutions. Additionally, global economic trends, such as supply chain dynamics and international collaborations, impact the availability and affordability of advanced diabetes care devices, ensuring their integration into the broader healthcare landscape.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.